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ABSTRACT 
Context Various techniques for reconstruction after superior mesenteric-splenic-portal vein confluence resection during 
pancreaticoduodenectomy have been introduced. A certain kind of vascular grafting may be necessary especially when long 
segmental resection of superior mesenteric-splenic-portal vein confluence is required. Case report We herein report the cases of two 
patients who underwent left renal vein grafting in a pancreaticoduodenectomy with combined resection of the long segment of the 
superior mesenteric-splenic-portal vein confluence for pancreatic head cancer following neoadjuvant concurrent chemoradiation 
therapy as well as their long-term outcomes with graft patency without deterioration of renal function. Conclusion Our experience 
with these two cases indicates that an autologous interposition graft using the left renal vein may be considered a safe and convenient 
conduit in the case of long segmental resection of the superior mesenteric-splenic-portal vein confluence during a 
pancreaticoduodenectomy following preoperative neoadjuvant chemoradiation therapy. 
 
INTRODUCTION 
 
A curative pancreaticoduodenectomy with negative 
margins offers the only latent cure for pancreatic head 
cancer. The oncologic outcome of a resection with 
positive margins is known to be as poor as in locally 
advanced pancreatic adenocarcinoma without surgical 
extirpation [1, 2, 3]. Pancreatic cancer invasion to the 
superior mesenteric-splenic-portal vein confluence is 
frequently encountered during a pancreatico-
duodenectomy due to their close anatomical 
relationship. However, superior mesenteric-splenic-
portal vein involvement in pancreatic cancer is no 
longer considered a contraindication to resection, 
thanks to recent advances in surgical techniques as well 
as perioperative management, and growing evidence 
demonstrates a better survival rate for en bloc removal 
with superior mesenteric-splenic-portal vein resection 
for isolated involvement of pancreatic cancer [3, 4, 5, 
6]. Several studies have demonstrated that venous 
resection during a pancreaticoduodenectomy is 
technically acceptable with no increase in perioperative 
morbidity [3, 6, 7, 8]. 
After segmental resection of the superior mesenteric-
splenic-portal vein system, a reconstruction method is 
decided upon according to the type and extent of the 
vascular resection, including primary end-to-end 
anastomosis, patch venoplasty and interposition 
grafting. In general, the majority of patients who 
undergo venous resection of the superior mesenteric-
splenic-portal vein confluence can restore portal vein 
flow via primary end-to-end anastomosis by 
mobilization of the mesentery. However, portal vein 
end-to-end anastomosis is often impossible not only 
because of longer segment of portal vein resection but 
also due to immobilization of the mesentery or superior 
mesenteric vein vessels. Inflammation extension to the 
mesentery by acute or chronic pancreatitis or fibrotic 
changes around the superior mesenteric-portal vein 
vessels induced by preoperative neoadjuvant 
concurrent chemoradiation therapy can be potential 
factors in sufficiently immobilizing the mesentery and 
the superior mesenteric vein, leading to difficulty with 
primary end-to-end anastomosis. In these cases, it is 
incumbent that the surgeon do the grafting portal vein 
reconstruction. In such cases, a left renal vein graft 
should be chosen for portal vein reconstruction because 
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the graft is more easily available and safer to use than 
other grafts [9, 10, 11, 12]. 
In this article, we report our experience with 
autologous vein interposition grafting using left renal 
vein. Follow-up imaging studies attest to the excellent 
outcome without deterioration of renal function and 
with maintenance of the graft patency. 
 
CASE REPORTS 
 
Case #1 
 
A 68-year-old man presented with epigastric and back 
pain of 1 month duration. His preoperative CT (Figure 
1a) and PET scans revealed a 3.5 cm pancreatic head 
cancer with suspicious invasion into the portal vein 
without distant metastasis, and an endoscopic 
ultrasonography (EUS) showed the portal vein 
involvement of the tumor in detail (Figure 1b). The 
serum CEA level was 1.55 ng/mL (reference range: 0-
5.00 ng/mL) and the CA 19-9 level was 757 U/mL 
(reference range: 0-37 U/mL). EUS-guided fine-needle 
biopsy confirmed an adenocarcinoma of the pancreas. 
He received neoadjuvant concurrent chemoradiation 
therapy according to our institutional policy for 
advanced pancreatic cancer. A partial response was 
identified on a follow-up study after the concurrent 
chemoradiation therapy, but vascular involvement was 
still suspected. We decided to perform a pancreatico-
duodenectomy with a possible segmental resection of 
the superior mesenteric-splenic-portal vein confluence, 
and left renal vein interposition grafting. 
Tumor involvement on the lateral border of the 
superior mesenteric-splenic-portal vein confluence was 
identified during the operation. It could have been 
direct tumor invasion or adhesions from the concurrent 
chemoradiation therapy, but it appeared to be 
impossible to isolate the vessels from the abutting area. 
In such circumstances, the access plane to the 
retroperitoneal margin should be changed from the 
lateral aspect to the medial (left lateral) aspect of the 
superior mesenteric-splenic-portal vein confluence. 
This dissection plane allowed for easy detachment of 
Figure 1. Preoperative imaging studies. a. CT of Case #1 showing pancreatic head cancer (arrow) with suspicious invasion to the portal vein. b. EUS 
of Case #1 revealing the tumor abutting on the portal vein (arrow). c. CT of Case #2 demonstrating pancreatic head cancer (arrows) invading the 
superior mesenteric-splenic-portal vein confluence. d. EUS of Case #2 clearly demonstrating the tumor abutting on the superior mesenteric-splenic-
portal vein confluence (arrow). 
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the uncinate process from the superior mesenteric 
artery. Division of the splenic vein completely freed the 
specimen except for the abutted segment of the 
superior mesenteric-splenic-portal vein confluence 
(Figure 2a), and the length of the vein to be resected 
was then measured. We usually prefer primary end-to-
end anastomosis as long as it can be carried out without 
a graft. A long segment of the vein, however, had to be 
resected and we expected potential tension at the 
anastomosis site in this case. Therefore, we continued 
to harvest the left renal vein as previously planned. The 
left renal vein was easily exposed with further 
extension of the previously performed Kocher 
maneuver and a 3.0 cm long segment of the left renal 
vein was grafted just proximal to the left adrenal and 
gonadal veins after clamping (Figure 2b). The 
remaining stumps were repaired with a running 5-0 
prolene suture. Proximal and distal vascular control 
was then achieved with Satinsky clamps, and a 
segment of the superior mesenteric-splenic-portal vein 
confluence was removed en bloc with the specimen 
(Figure 2c). The resected segment of the superior 
mesenteric-splenic-portal vein confluence was 
reconstructed using the left renal vein graft, and no 
tension was observed (Figure 2d). The clamping time 
of the portal flow required about 25 minutes to 
complete vascular reconstruction. We systemically 
heparinized before vascular clamping, and neutralized 
with protamine sulfate immediate after the removal of 
the vascular clamping. After venous reconstruction, the 
gastrointestinal reconstructions were completed. We 
routinely use low molecular weight heparin (Clexane®, 
Sanofi-Aventis, Paris, France) after a pancreatico-
duodenectomy to prevent postoperative thrombo-
embolism; it is administered via subcutaneous injection 
for four days starting at postoperative day three. No 
anticoagulant therapy with warfarin or aspirin was 
administered postoperatively for vascular resection. 
The pathologic report confirmed a ductal adeno-
carcinoma of the pancreas and complete R0 resection. 
He had delayed gastric emptying during the 
postoperative period, but this was resolved with 
conservative management. A follow-up CT 
demonstrated a patent graft (Figure 3a), good collateral 
flow and a well-perfused left kidney (Figure 3b). 
Postoperative follow-up serum creatinine levels were 
maintained within the normal range (varing between 
0.60 and 1.16 mg/dL; reference range: 0-50-1.40 
Figure 2. Operative findings of Case #1. a. Division of the splenic vein completely freed the specimen except for the abutting segment of the 
superior mesenteric-splenic-portal vein confluence. Arrows indicate the resected splenic vein. b. A segment of the left renal vein was grafted. c. A 
segment of the superior mesenteric-splenic-portal vein confluence was removed en bloc with the specimen and was reconstructed using a left renal 
vein graft. d. No tension was observed after reconstruction. 
LRV: left renal vein; P: pancreas; PV: portal vein; SMA: superior mesenteric artery; SMV: superior mesenteric vein; SV: splenic vein; VC: vena cava 
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mg/dL) (Figure 3c). Renal function preservation was 
verified by the development of collaterals on follow-up 
CT. He was revealed to have multiple liver metastasis 
19 months after the operation, and died after 21 
months. 
 
Case #2 
 
A 48-year-old woman was admitted with weight loss of 
one month duration and jaundice of five days duration. 
Her preoperative CT also demonstrated pancreatic head  
 
Figure 3. Follow-up of Cases #1 and #2. a. CT of Case #1 demonstrating a patent portal flow (arrow). b. CT of Case #1 showing development of 
collaterals (arrow) and a well-perfused left kidney. c. Postoperative follow-up serum creatinine levels of Case #1 were maintained within the normal 
range. d. CT of Case #2 showing a patent portal flow (arrow). e. CT of Case #2 revealing well-developed collaterals (arrow) and good perfusion of 
the left kidney. f. The postoperative follow-up serum creatinine levels of Case #2 were maintained within the normal range. 
Cr: creatinine; BUN: blood urea nitrogen; LRV: left renal vein; POD#1mon: 1-month postoperative; POD#1yr: 1-year postoperative; PreOP: 
preoperative 
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cancer invading the superior mesenteric-splenic-portal 
vein confluence (Figure 1c), and mild uptake was 
identified on a PET scan. EUS clearly showed the 4.0 
cm pancreatic head cancer abutting on the superior 
mesenteric-splenic-portal vein confluence (Figure 1d). 
The serum CEA level was 3.40 ng/mL and the CA 19-9 
level was 660 U/mL. Adenocarcinoma of the pancreas 
was confirmed by EUS-guided fine-needle biopsy. 
Neoadjuvant concurrent chemoradiation therapy for 
advanced pancreatic cancer was carried out, and stable 
disease was identified on follow-up studies after 
concurrent chemoradiation therapy. 
Vascular involvement of the pancreatic head cancer 
was still suspected; therefore, she also underwent a 
pancreaticoduodenectomy combined with a segmental 
resection of the superior mesenteric-splenic-portal vein 
confluence and left renal vein interposition grafting 
using almost the same technique as in Case #1 (Figure 
4). The length of the left renal vein graft was 3.5 cm 
and the portal flow clamping time was 20 minutes. 
Clexane® was also administered for four days without 
warfarin or heparin. 
The histopathological examination of the en bloc 
specimen disclosed a ductal adenocarcinoma of the 
pancreas and an R0 resection. She was discharged on 
the 16th operative day after an uneventful recovery. A 
follow-up CT scan one month postoperatively also 
showed a patent graft (Figure 3d), good collateral flow 
and a well-perfused left kidney (Figure 3e). 
Postoperative follow-up serum creatinine levels were 
maintained within the normal range (between 0.33 and 
0.86 mg/dL) (Figure 3f). She showed no evidence of 
recurrence at her last follow-up (23 months 
postoperatively). 
 
DISCUSSION 
 
Isolated superior mesenteric-splenic-portal vein 
confluence involvement by malignancy is no longer 
regarded as a contraindication for resection of 
pancreatic head cancer, even though some argue that 
the prognosis depends on the depth of invasion [13]. 
Isolated venous involvement of the tumor is distinct 
from invasion of the circumferential (left lateral) wall 
of the superior mesenteric-splenic-portal vein 
confluence or the superior mesenteric artery, which 
demonstrates frequent involvement of the mesenteric 
neural plexus and makes it impossible to achieve a 
tumor free margin [3, 13, 14]. Therefore, surgical 
Figure 4. Operative findings of Case #2. a. Division of the splenic vein completely freed the specimen except for the abutting segment of the 
superior mesenteric-splenic-portal vein confluence. Arrows indicate the resected splenic vein. b. A segment of the left renal vein was grafted. c. A 
segment of the superior mesenteric-splenic-portal vein confluence was removed en bloc with the specimen. d. No tension was observed after 
reconstruction. 
LRV: left renal vein; P: pancreas; PV: portal vein; SMA: superior mesenteric artery; SMV: superior mesenteric vein; SV: splenic vein; VC: vena cava. 
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strategy for isolated venous involvement is thought to 
have potential oncologic benefits [15]. 
Options for a venous conduit for reconstruction after 
superior mesenteric-splenic-portal vein confluence 
resection include prosthetic, autologous or 
cryopreserved cadaveric vein grafts. Despite its ready 
availability and valid size match, the use of a prosthetic 
graft such as polytetrafluoroethylene (PTFE) is not 
indicated due to the potential risk of infection and 
thrombosis [16]. The portal vein has medium velocity 
but a high volume flow. Therefore, some reports have 
demonstrated that the use of PTFE interposition grafts 
did not increase the risk of thrombosis [17]. However, 
Smoot et al. [18] reported a higher percentage of 
thrombosis in PTFE grafts, and they changed to the left 
renal vein as the preferred conduit. As for selecting 
potential autologous grafts for the superior mesenteric-
splenic-portal, the internal jugular, femoral, great 
saphenous, gonadal, common iliac, external iliac and 
splenic veins are all candidates [8, 11, 12, 16, 19]. 
However, the great saphenous and gonadal veins have 
a size disparity which requires some modification to be 
applied as a portal vein graft. Therefore, these veins 
cannot be used in the same way as the internal jugular 
vein and the others listed above. Furthermore, 
harvesting these autologous veins requires creating an 
additional wound and is associated with other 
postoperative complications, such as lymphedema and 
venous thrombosis. From this point of view, the left 
renal vein has several advantages, such as suitable 
length, comparable caliber to superior mesenteric-
splenic-portal vein confluence, easy accessibility 
during pancreaticoduodenectomy and the fact that it is 
a safe procedure [9, 10, 11, 12, 20]. Furthermore, all 
routes for central venous access can be maintained 
when using the left renal vein, which is especially 
important in patients who have undergone a major 
operation such as a pancreaticoduodenectomy. Left 
renal vein grafting is also justified because the left 
renal vein has various collateral branches, such as the 
inferior phrenic and adrenal tributaries, the gonadal 
vein, renal-azygos communication, and splenorenal 
communication; therefore, there is no deterioration of 
renal function after harvesting the left renal vein [10, 
12, 20, 21]. The follow-up CT in our cases clearly 
showed that the development of collaterals enabled the 
preservation of the renal function. The segment of the 
left renal vein can be extended onto the portion just 
distal to the renal-azygos branch to preserve the 
gonadal and renal-azygos venous drainage essential for 
preservation of the renal function [9, 22]. This usually 
provides a segment of about 3-4 cm in length of renal 
vein graft [10, 11]. Harvesting of the graft and 
resection of the involved segment of the superior 
mesenteric-splenic-portal vein confluence should 
follow the completion of the dissection of the 
retroperitoneal margin so as to properly assess the need 
for interposition grafting and minimize the clamping 
time of the portal flow. In our cases, left renal vein 
resection did not increase the serum creatinine level 
during long-term follow-up, and the graft patency and 
well-maintained collateral flow was confirmed by 
follow-up radiologic images. The patients’ survival 
outcome was acceptable. 
In conclusion, our preliminary experience with these 
two patients indicates that autologous interposition 
grafting using the left renal vein can be considered as a 
safe and convenient conduit for segmental resection of 
the superior mesenteric-splenic-portal vein confluence 
during pancreaticoduodenectomy following pre-
operative neoadjuvant concurrent chemoradiation 
therapy in pancreatic cancer initially designated as 
being non-resectable. 
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